Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session

scientific article

Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5152/DIR.2014.13345
P932PMC publication ID4289157
P698PubMed publication ID24509182
P5875ResearchGate publication ID260130242

P50authorAnthony HoangQ90654296
Lambros StamatakisQ97527341
Maria J MerinoQ107749611
Hayet AmalouQ114421918
Annerleim Walton-DiazQ114421922
Srinivas VourgantiQ114421924
Mohummad Minhaj SiddiquiQ37831177
Soroush Rais-BahramiQ40114897
Bradford J. WoodQ40114938
Baris TurkbeyQ88769455
Jeffrey NixQ89071956
Cheng William HongQ89304800
Peter L ChoykeQ90059714
Peter A PintoQ90059716
P2093author name stringSheng Xu
P2860cites workScreening for prostate cancerQ24201690
MRI of localized prostate cancer: coming of age in the PSA eraQ27002672
Cancer statistics, 2013Q27860762
Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound BiopsiesQ30047599
Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imagingQ34021950
Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?Q34534796
Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancerQ34918676
D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imagingQ35202301
Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imagingQ35354750
Documenting the location of prostate biopsies with image fusionQ35738511
Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion deviceQ36579232
Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomyQ37007165
Real-time MRI-TRUS fusion for guidance of targeted prostate biopsiesQ37149144
Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigenQ37381526
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised diseaseQ37807744
The impact of prostate biopsy on urinary symptoms, erectile function, and anxietyQ38039328
Ultrasound guided transrectal core biopsies of the palpably abnormal prostateQ39278520
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancerQ39391979
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancerQ40114843
Active surveillance program for prostate cancer: an update of the Johns Hopkins experienceQ45133435
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.Q45967722
Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?Q48006856
Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?Q74591846
P433issue3
P304page(s)234-238
P577publication date2014-05-01
P1433published inDiagnostic and interventional radiology : official journal of the Turkish Society of RadiologyQ26842393
P1476titleImaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session
P478volume20